EP3234081A1 - Verfahren zur verbesserung der palmölausbeute aus der palmenfrucht oder aus palmenfruchtflüssigkeit - Google Patents

Verfahren zur verbesserung der palmölausbeute aus der palmenfrucht oder aus palmenfruchtflüssigkeit

Info

Publication number
EP3234081A1
EP3234081A1 EP15820488.3A EP15820488A EP3234081A1 EP 3234081 A1 EP3234081 A1 EP 3234081A1 EP 15820488 A EP15820488 A EP 15820488A EP 3234081 A1 EP3234081 A1 EP 3234081A1
Authority
EP
European Patent Office
Prior art keywords
palm
oil
enzyme
palm fruit
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP15820488.3A
Other languages
English (en)
French (fr)
Inventor
Jørn Borch Søe
René MIKKELSEN
Lai See LEE
Karina Hansen Kjaer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DuPont Nutrition Biosciences ApS
Original Assignee
DuPont Nutrition Biosciences ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DuPont Nutrition Biosciences ApS filed Critical DuPont Nutrition Biosciences ApS
Publication of EP3234081A1 publication Critical patent/EP3234081A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B13/00—Recovery of fats, fatty oils or fatty acids from waste materials
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00—Production of fats or fatty oils from raw materials
    • C11B1/02—Pretreatment
    • C11B1/025—Pretreatment by enzymes or microorganisms, living or dead
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00—Production of fats or fatty oils from raw materials
    • C11B1/06—Production of fats or fatty oils from raw materials by pressing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02W—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO WASTEWATER TREATMENT OR WASTE MANAGEMENT
    • Y02W30/00—Technologies for solid waste management
    • Y02W30/50—Reuse, recycling or recovery technologies
    • Y02W30/74—Recovery of fats, fatty oils, fatty acids or other fatty substances, e.g. lanolin or waxes

Definitions

  • the present invention relates to a method for the treatment of palm fruit or a portion thereof or palm fruit extract (or pressed palm fruit extract also known in the industry as “pressed liquid” or “pressed oil”) with at least a cellulase.
  • the method results in a decrease in oil in sediment, a decreased viscosity of the oil obtained from the palm fruit or portion thereof or palm fruit extract (e.g. pressed palm fruit extract), improved palm oil yields, and/or an increase in fermentable sugars in the aqueous phase.
  • Palm oil obtained from oil palm (Elaeis guineensis) is commercially important edible oil. Palm oil has been a prominent fat and oil resource for the food industry due to several advantageous properties, such as high productivity, low price, high thermal and oxidative stability and plasticity at room temperature. Additionally, compared with other vegetable oils, palm oil is a rich source of the anti-oxidant vitamin E.
  • palm oil was 50 million ton/year, which in quantity makes it the most important vegetable oil produced. It is estimated that 4-8% of palm oil is lost during processing. This loss can be split up as follows: 0.8-1 % is lost in the palm mesocarp fibre, 1.5-2.7% is lost from the empty fruit bunch (EFB); and more than about 1 % is lost in oil mill effluent (Ho et al., JAOCS, Vol. 69, No. 3 (1992)). The percentage calculation is based on fresh fruit bunches.
  • Figure 1 shows flow diagram for palm oil processing.
  • Production of crude palm oil is conducted by a series of unit operations starting with a sterilization of the fresh fruit bunch (FFB). After sterilization, the fruits are stripped from the bunch and digested. During the digestion, the palm fruit is disintegrated and oil released from the mesocarp. After digestion, the crude oil is separated from fiber by pressing the digested fruits.
  • FFB fresh fruit bunch
  • the pressed palm oil contains crude palm oil, water and solid debris. Crude palm oil is separated under the influence of gravity from the pressed liquid by clarification in a clarification tank. Crude palm oil that is discharged from the presses is highly viscous. Thus, separation of the oil from the solid and water is difficult without the addition of dilution water. Hot water is therefore added to the pressed liquid to dilute it prior to or during clarification. This typically occurs using a temperature range of 80-90 °C. The dilution provides a barrier causing the heavy solid to settle to the bottom of the clarification tank while the lighter oil droplets rise through the sludge phase to the top when heat is applied.
  • centrifuge sludge is a viscous liquid containing water, about 0.5-1.5% oil, and about 5-10% non-oil solids. For each ton of oil produced, 1-1.5 ton of centrifuge sludge is produced. The centrifuge sludge thus presents a substantial loss of oil. During these initial processing steps, 90-92% of the theoretical palm oil amount is obtained, but there is a significant oil loss to the fiber (e.g. press cake) during processing as well as oil loss during downstream processing.
  • palm oil is often not essential as the level of non-hydratable phosphorus can be naturally low in this product, especially in comparison to other vegetable oils.
  • the phosphorus content of palm oil is about 15-30 ppm which is very low when compared to e.g. corn oil (250-800 ppm), cottonseed (400-1000 ppm), rapeseed (200-1400 ppm), soya (400-1200 ppm) or sunflower (200-500 ppm).
  • corn oil 250-800 ppm
  • cottonseed 400-1000 ppm
  • rapeseed 200-1400 ppm
  • soya 400-1200 ppm
  • sunflower 200-500 ppm
  • the present invention provides a method of improving palm oil yields and/or decreasing oil in sediment or sludge and/or increasing fermentable sugars in the aqueous phase, which method comprises:
  • the present invention provides use of an enzyme composition comprising cellulase activity in combination with a palm fruit or a portion thereof or a palm fruit liquid, wherein said palm fruit or portion thereof or palm fruit liquid when admixed with the enzyme composition comprises at most 40% water content w/w in the manufacture of palm oil for improving palm oil yield, for improving separation of palm oil from the sludge phase, for producing an aqueous phase with improved fermentable sugars, or for improving the speed of oil separation.
  • the present invention provides a palm oil phase, a sludge phase or an aqueous phase obtainable (preferably obtained) by the method according to the present invention.
  • the present invention provides the use of an aqueous phase obtained (preferably obtained) by the method of the present invention as a fermentation medium.
  • the present invention yet further provides a method for producing a fermentation product comprising fermenting a feedstock comprising said aqueous phase (or a portion thereof) obtainable (preferably obtained) by the method according to the present invention and recovering said fermentation product.
  • Figure 1 shows a flow diagram for Palm Oil processing.
  • Figure 2 shows pressed palm liquid after enzyme treatment and centrifugation.
  • Figure 3 shows the effect of LAM IN EX® BG2, -Super 3G, -750 and -C2K on residual oil in sediment after centrifugation.
  • Figure 4 shows the effect of LAM IN EX® BG2, -Super 3G, -750 and -C2K on amount of dry sediment after centrifugation.
  • Figure 5 shows the effect of LAM IN EX® BG2, -Super 3G, -750 and -C2K on water in sediment after centrifugation.
  • Figure 6 shows the effect of LAM IN EX® BG2, -Super 3G, -750 and -C2K on content of glucose in water phase after centrifugation.
  • Figure 7 shows the effect of water dilution at different temperatures on viscosity of PALM_2.
  • Figure 8 shows the effect of water dilution at different temperature on viscosity of PALM_2 treated with 0,5% LAM IN EX® BG2.
  • Figure 9 shows oil separation of samples from Table 7 after 10 minutes.
  • Figure 10 shows the effect of water dilution at different temperature on viscosity of PALM_1.
  • Figure 11 shows the effect of water dilution at different temperature on viscosity of PALM_1 treated with 0,5% LAMINEX® BG2.
  • Figure 12 shows oil separation of samples from Table 9 after 10 minutes.
  • Figure 13 shows the effect of water dilution at different temperature on viscosity of PALM_8.
  • Figure 14 shows the effect of water dilution at different temperature on viscosity of PALM_8 treated with 0,5% LAMINEX® BG2.
  • Figure 15 shows oil separation of samples from Table 1 1 after 10 minutes.
  • Figure 16 shows pressed palm liquid samples from Table 13 after reaction and separation for 10 minutes.
  • a white line indicates a boundary between sludge and oil.
  • Figure 17 shows % Oil separated after 10 minutes settling of samples from Table 13.
  • Figure 18 shows the effect of enzyme treatment on oil in dry sediment after centrifugation of samples from Table 13.
  • Figure 19 shows the effect of enzyme treatment on water content in wet sediment after centrifugation of samples from Table 13.
  • Figure 20 shows the effect of enzyme treatment on amount of dry sediment after centrifugation of samples from Table 3.
  • Figure 21 shows the effect of LAMINEX® BG2 and water on viscosity of pressed palm liquid from Table 17.
  • Figure 22 shows the effect of LAMINEX® BG2 and water dilution on oil in sediment from samples in Table 17.
  • a seminal finding of the present invention is that treatment of palm fruit or a portion thereof or palm fruit extract (e.g. pressed palm fruit extract also known in the industry as “pressed liquid” or “pressed oil” or “pressed palm liquid”) with celiulase to reduce oil in sediment/sludge and/or increase oil yields is enhanced by ensuring that the palm fruit or a portion thereof or palm fruit extract (e.g. pressed palm fruit liquid) comprises at most 40% water content w/w.
  • palm fruit extract e.g. pressed palm fruit extract also known in the industry as "pressed liquid” or “pressed oil” or “pressed palm liquid
  • the method of the present application also advantageously reduce the viscosity of crude palm oil allowing easier and/or faster and/or more efficient separation of crude palm oil, e.g. from sludge.
  • the present invention provides use of an enzyme composition comprising celiulase activity in combination with a palm fruit or a portion thereof or a palm fruit liquid, wherein said palm fruit or portion thereof or palm fruit liquid when admixed with the enzyme composition comprises at most 40% water content w/w in the manufacture of palm oil for improving palm oil yield, for improving separation of palm oil from the sludge phase, for producing an aqueous phase with improved fermentable sugars, or for improving the speed of oil separation.
  • the incubation may be between about 1 hour and about 8 hours.
  • the incubation may be between about 4 hours and about 8 hours. In one embodiment the temperature may be between 50 to 90 °C, suitably between about 55 to about 65°C.
  • the admixture may be incubated at about 70 °C to about 95 °C, more preferably at about 80 to about 95 °C.
  • said palm fruit or portion thereof or palm fruit liquid when admixed with said enzyme composition comprises at most 38% water content w/w, suitably at most 35% water content w/w, suitably at most 30% water content w/w.
  • palm fruit liquid is a pressed palm fruit liquid.
  • the oil may be separated from the sediment and/or aqueous phase by any method known in the art.
  • the oil may be separated by gravity (e.g. by
  • the oil may be separated by centrifugation either instead of gravitation separation or in addition to separation by gravity.
  • the separation results in a triple phase composition comprising an oil layer, an aqueous layer and a substantially solid sediment (or sludge) layer.
  • the aqueous phase may be enriched in soluble fermentable sugars.
  • the sludge phase produced by the method of the present invention has less dry solids compared with the sludge phase from a control (non-enzyme treated sample).
  • the present invention yet further provides the use of an aqueous phase obtained
  • the present invention yet further provides a method for producing a fermentation product comprising fermenting a feedstock comprising said aqueous phase (or a portion thereof) obtainable (preferably obtained) by the method according to the present invention and recovering said fermentation product.
  • the feedstock used in accordance with the present invention may in addition to the aqueous phase further comprise empty palm fruit bunches or processed empty palm fruit bunches.
  • processed empty palm fruit bunches means empty palm fruit bunches which have undergone one or more processing steps, e.g. milling or chemical treatment, e.g. acid treatment or alkaline treatment.
  • a further surprising finding is that the resulting aqueous phase after separation from the oil, e.g. by centrifugation, is enriched in fermentable sugars.
  • the inventors have found that this aqueous phase can be used either alone or in combination with empty palm fruit bunches or processed empty palm fruit bunches as a substrate for fermentation, e.g. in the production of a fermentation product such as biofuel (e.g., ethanol or butanol).
  • the empty palm fruit bunches may be pretreated prior to use for fermentation.
  • the empty palm fruit bunches may be milled and/or chemically treated by alkaline ammonia treatment or acid pretreatment.
  • the fermentation product in accordance with the present invention may be a compound selected from the group consisting of: an alcohol (e.g. a biofuel (e.g. ethanol, butanol or a combination thereof), an antibiotic, an antimicrobial, a bioinsecticide, a solvent, a
  • the conversion of a substrate for fermentation to an end product involves the use of an enzymatic conversion by a known enzyme to the desired end-product using known enzymatic conversion methods.
  • the conversion of glucose to a desired end product is accomplished by the addition of an amount of an enzyme known to convert glucose to the specified end product desired.
  • enzymes useful for the conversion of a sugar to 1 ,3-propanediol may include, but are not limited to, enzymes produced by E. coll and other microorganisms.
  • enzymes useful for the conversion of a sugar to lactic acid include, but are not limited to, those produced by Lactobacillus and Zymomonas.
  • Enzymes useful for the conversion of a sugar to ethanol include, but are not limited to alcohol dehydrogenase and pyruvate decarboxylase.
  • Enzymes useful for the conversion of a sugar to ascorbic acid intermediates include, but are not limited to glucose dehydrogenase, gluconic acid dehydrogenase, 2,5- diketo-D-gluconate reductase, and various other enzymes.
  • Enzymes useful for the conversion of a sugar to gluconic acid include, but are not limited to glucose oxidase and catalase.
  • the desired end-product can be any product that may be produced by the enzymatic conversion of the substrate to the end-product.
  • gluconate can be converted from glucose by contacting glucose with glucose dehydrogenase (GDH).
  • GDH glucose dehydrogenase
  • gluconate itself can be converted to 2-KDG (2-keto-D-gluconate) by contacting gluconate with GDH.
  • 2-KDG can be converted to 2,5-DKG by contacting 2-KDG with 2- KDGH.
  • Gluconate can also be converted to 2-KDG by contacting gluconate with 2KR.
  • Glucose can also be converted to 1 ,3-propanediol by contacting glucose with E. coli.
  • glucose can be converted to succinic acid by contacting glucose with E. coli.
  • glucose in some embodiments in which glucose is an intermediate, it is converted to ethanol by contacting glucose with an ethanologenic microorganism.
  • an intermediate converting enzyme it is contemplated that isolated and/purified enzymes are placed into contact with the intermediate.
  • the intermediate is contacted with bioconverting agents such as bacteria, fungi or other organism that takes in the intermediate and produces the desired end-product.
  • the organism is wild-type, while in other embodiments it is mutated.
  • ethanologenic microorganisms include ethanologenic bacteria expressing alcohol dehydrogenase and pyruvate decarboxylase, such as can be obtained with or from Zymomonas mobilis (See e.g., U.S. Pat. Nos. 5,028,539, 5,000,000, 5,424,202, 5,487,989, 5,482,846, 5,554,520, 5,514,583, and copending applications having U.S. Ser. No. 08/363,868 filed on Dec. 27, 1994, U.S. Ser. No. 08/475,925 filed on Jun. 7, 995, and U.S. Ser. No. 08/218,914 filed on Mar. 28, 1994, each of which is incorporated herein by reference).
  • the feedstock may be subjected to one or more processing steps selected from the group consisting of: milling, cooking and/or
  • a further surprising finding of the present invention is that the enzyme incubation preferably takes place without or with only minimal agitation.
  • the enzyme composition comprising cellulase for use in the methods and uses of the present invention is thermostable.
  • thermostable enzyme composition comprising cellulase in combination with a palm fruit or a portion thereof or a palm fruit liquid, wherein said palm fruit or portion thereof or palm fruit liquid when admixed with the enzyme composition comprises at most 40% water content w/w in the manufacture of palm oil for improving palm oil yield, for improving separation of palm oil from the sludge phase, for producing an aqueous phase with improved fermentable sugars, or for improving the speed of oil separation.
  • the enzyme incubation according to the present invention may be performed at any stage in the palm fruit processing plant following removal of palm fruitlet from the bunch.
  • the inventors have found that it may be undesirable to carry out this reaction in the digester.
  • Current digester conditions are highly optimized to physically disintegrate the fruit so that the liquids can be pressed out. This takes place typically at 95 °C.
  • the enzyme composition is incubated with the palm fruit or a portion thereof before the digestor, e.g. in a precooker.
  • the temperature in the precooker may be lower than the temperature in the digester, e.g. less than 95 °C.
  • the enzyme composition is incubated with palm fruit extract (e.g. pressed palm fruit liquid) either just before or during clarification (e.g. just before or in the clarifier).
  • palm fruit extract e.g. pressed palm fruit liquid
  • the method of the present invention further comprises separating palm oil (crude palm oil) from sludge.
  • the crude palm oil may be separated from the sludge by clarifying, decanting or a combination thereof.
  • the crude palm oil may be separated from the sludge by centrifugation.
  • the palm fruit extract for use in the methods and/or uses of the present invention may be a pressed palm fruit liquid.
  • the admixing of the at least one enzyme(s) and palm fruit or a portion thereof may occur during digestion of one or more palm fruit(s) or a portion thereof prior to pressing, preferably wherein the at least one enzyme(s) is added to the digester.
  • the at least one enzyme(s) may be admixed with a palm fruit extract after being pressed.
  • the palm fruit extract is a pressed palm fruit extract and the admixing occurs prior to or during separation of crude palm oil from sludge.
  • the admixture as defined in the method of the present invention may be incubated for about 2 hours.
  • the method may comprise applying the enzyme composition to the palm fruit or a portion thereof or a palm fruit extract by: (a) spraying; (b) admixing the enzyme composition with water added to the digester (so long at the total water content does not exceed the maximum 40% w/w); (c) pouring the at least one enzyme into a vessel with the palm fruit or a portion thereof or palm fruit extract; or (d) combinations thereof.
  • the enzyme or thermostable enzyme may be immobilized, e.g. to a surface or cross-linked.
  • the enzyme or thermostable enzyme may be cross-linked using glutaraldehyde (Migneault et al., BioTechniques 37: 790:802 (2004)).
  • the separation of the crude oil from the sludge may be carried out by clarification.
  • “Clarification”, as used herein, means using gravity to allow the oil to settle out of the sludge. During clarification the oil becomes “clear”. Clarification
  • the present method provides admixing the enzyme composition with a palm fruit liquid (which comprises at most 40% water content) in the clarifier and incubating at a temperature of between 50 and 70 °C for 0.5 to 8 hours. Reducing the temperature in the clarifier can has significant advantages as the exposure of the oil to temperatures of 90 to 95 X can have a negative effect on the quality of the oil and/or cause oxidation of the oil.
  • settling tanks such as vertical clarifiers
  • the crude oil settles out of the sludge.
  • the oil may be skimmed off the sludge.
  • this sludge is typically called the "underflow”).
  • "Sludge” as used herein is a heavy fraction of pressed palm fruit extract comprising oil, water and some organic material that has a tendency to settle out of pressed palm fruit extract.
  • Sludge may be obtained by clarification, for example following separation as shown in Figure 1.
  • Separation of the oil may be into 2-phases or 3-phases.
  • a 2-phase system e.g. separation into an oil phase and a sludge phase
  • the sludge phase is enriched in soluble fermentable sugars.
  • a 3-phase system e.g. separation into an oil phase, an aqueous phase and a sludge phase
  • the aqueous phase is enriched in soluble fermentable sugars.
  • the phase enriched in soluble fermentable sugars may be used as a fermentation media, e.g. for the production of an alcohol (e.g. bioethanol) or other fermentation product as set forth herein.
  • Mechanisms may be employed to improve recovery of residual oil from the settled sludge (e.g. post clarification). For example a centrifuge may be used to extract further oil from the sludge. Typically therefore the sludge may be sent to a centrifuge.
  • a decanter may be used in combination with clarification.
  • 3-phase centrifuges or decanters may be employed.
  • a 3-phase decanter is available as "Westfalia SEPARATOR® topd 3-Phase Decanter” may be used to separate the sludge from the clarification process into 3-phases: an oil-phase, solids, and virtually oil-free waste water.
  • nozzle-type separates such as the one from GEA Westfalia may be used which separate the sludge from the clarification step into three phases: palm oil, solid concentrate and water.
  • the separation of the crude oil from the sludge may be carried out by decanting (e.g. without clarification).
  • Decanters (3-phase) available as "Westfalia SEPARATOR® topd 3- Phase Decanter” can be used directly with enzyme treated pressed palm fruit extract without clarification (GEA Westfalia, Oelde, Germany). This may have the advantage of shorter processing time, smaller dimensions of the process lines. Also the risk of oxidation of the crude oil is less significant compared to the process using vertical clarifiers. Such a decanter separates the sludge into 3-phases: an oil-phase, a dry solids cake, and virtually oil-free waste water. Centrifugation may be used during or after the decanting process.
  • the method may further comprise purifiers downstream of the separation step (e.g. downstream of the clarification and/or decanting stage).
  • the purifiers may remove even extremely small amounts of oil left in the effluent.
  • the present methods may further comprise a desanding step - which step removes sand to avoid erosion problems caused thereby.
  • the sand may be removed by any method known to one skilled in the art. As the skilled person will appreciate, a multicyclone system may be used to separate the sand. Typically the desanding step may occur prior to the centrifugation step.
  • the pressed palm fruit extract may be prepared by sterilizing the fresh palm fruit bunches, stripping the fruit from the sterilized bunches, optionally digestion of the fruit, and pressing.
  • the digestion may take place in a digester. During the digestion, the palm fruit is disintegrated and oil released from the fiber. After digestion, the crude oil is separated from the fiber by pressing the digested fruits.
  • the term "palm fruit extract”, as used herein, may mean an extract obtained during sterilization of the fresh palm fruit bunches, stripping the fruit from the bunches, and optionally digestion of the fruit prior to pressing.
  • pressed palm fruit extract means an extract post-pressing.
  • pressed palm fruit extract may arise from the pressing step indicated in the flow diagram of Figure 1 and the pressed palm fruit extract or pressed oil may then be subject to further processing steps, e.g. screening, clarification, desanding, separation, purification, drying etc.
  • the method may include removing large solid particulates/course fibres from the pressed palm fruit extract - e.g. this may be achieved by passing the pressed palm fruit extract through a screen which may be vibrating. This additional step may be carried out before clarification and/or decanting.
  • the enzyme for use in the present invention is admixed with one or more palm fruit(s) or a portion thereof prior to pressing.
  • the palm fruit(s) or portion thereof is/are admixed with the enzyme during a digestion step.
  • the palm fruit or portion thereof may be admixed with the enzyme in a digester.
  • the enzyme may be added to palm fruit(s) prior to removal of the kernel (otherwise known as the nut).
  • the enzyme for use in the present invention may be admixed with digested palm fruit or portion thereof prior to pressing.
  • the enzyme may be admixed with palm fruit or a portion thereof in an enzyme reaction tank.
  • such admixing may be prior to digestion of said palm fruit or portion thereof.
  • the admixture may be incubated at a temperature and/or time that are optimised for digestion of said palm fruit or the portion thereof. It will be appreciated that the person skilled in the art will be capable of determining such a time empirically based on routine experimentation.
  • the term "or a portion thereof in relation to the palm fruit(s) means the part of the palm fruits that are remaining post stripping the fruit from the bunches.
  • the enzyme composition may be admixed with or applied to the palm fruit or portion thereof or palm fruit extract by any suitable means known in the art.
  • the aim when admixing the enzyme with the palm fruit or a portion thereof or palm fruit extract is to ensure good coverage of the enzyme on the palm fruit (or portion thereof or palm fruit extract).
  • the enzyme composition may be applied to the palm fruit or a portion thereof or palm fruit extract by spraying, admixing the at least one enzyme, pouring the at least one enzyme into a vessel with the palm fruit or portion thereof or palm fruit extract, or combinations thereof.
  • admixed encompasses mixing, pouring, spraying, misting or other suitable means of contacting the enzyme(s) with the palm fruit or portion thereof or palm fruit extract.
  • the enzyme composition when the enzyme composition is admixed with or applied to the palm fruit or portion thereof or palm fruit extract this may occur behind a protective surface (e.g. a screen or a curtain).
  • a protective surface e.g. a screen or a curtain.
  • application behind a protective surface protects the individual(s) performing the application or admixing and minimises any negative effects to human health that could ensue by exposure (e.g. through inhalation) to the enzyme composition.
  • the palm fruit or a portion thereof or the palm fruit extract may be one having a diglyceride content of about 3% w/w to about 8% w/w of total lipid content.
  • the enzyme for use in the present invention may be admixed with pressed palm fruit extract prior to separating the crude palm oil from the sludge (e.g. by clarification or decanting or centrifugation).
  • the enzyme for use in the present invention may be admixed with pressed palm fruit extract during the separation step, e.g. when the crude palm oil is being separated from the sludge (e.g. by clarification or centrifugation).
  • the enzyme for use in the present invention may be admixed with pressed palm fruit extract during clarification (e.g. in the clarifying tank).
  • the enzyme may be added into the flow stream of pressed palm liquid pumped into the clarifier (e.g. the clarifying tank).
  • the clarifier e.g. the clarifying tank
  • One preferred mechanism for recovery of residual oil in the sludge is centrifugation.
  • pressed palm fruit extract is also known in the industry as “pressed liquid” or “pressed oil”. These terms are used interchangeably herein.
  • pressed palm fruit extract is not a crude palm oil or semi-crude palm oil and has typically not been water or enzymatically degummed.
  • a crude palm oil is the resulting oil that is purified and dried prior to shipment to refining/degumming plants.
  • Crude palm oil has three main components, which are a mixture of oil and water, oil- in-water emulsions and water-in-oil emulsions.
  • a crude palm oil is typically separated into pure oil and sludge in a clarifying station (Stork, G. (1960) Stork: Palm Oil Review, Gebr. Stork
  • the pressed palm fruit extract is a composite containing: oil, water and non-oil solids (comprising lignin, carbohydrates, proteins and inorganic solids).
  • the mixture is an emulsion of oil-in-water from which the oil is separated.
  • the pressed palm fruit extract comprises typically approximately 64% oil, 24% water, 12% non-oil solids (Maycock et al. (1987) supra) (comprising lignin, carbohydrate, proteins and inorganic solids). It will be known to one skilled in the art that the levels of each of these components in the pressed palm fruit extract may vary depending on the starting palm fruits used, which vary according to location and year of harvest as well as, for example, the amount of water in the fruit.
  • the amount of water in the fruit may vary depending on the whether the climate conditions are wet or dry during harvest, for example.
  • a pressed palm fruit extract for use in the present method typically has at least 50% oil.
  • the water content of a pressed palm fruit extract for use in the present method is below 40%.
  • 7-10% w/w (e.g. 8.5% w/w) of the total non-oil solids in pressed palm fruit extract is protein. Therefore in one embodiment the present invention relates to a palm fruit extract (e.g. a pressed palm fruit extract) that comprises at least 7% w/w (suitably at least 8.4% w/w) total non-oil solids.
  • the present method comprises a palm fruit extract (e.g. a pressed palm fruit extract) that comprises at from at least about 6.5% to about 12% w/w total non-oil solids.
  • the present method is directed to a palm fruit extract (e.g. a pressed palm fruit extract that comprises at least 0.5%, preferably at least 1 % w/w protein).
  • a palm fruit extract e.g. a pressed palm fruit extract that comprises at least 0.5%, preferably at least 1 % w/w protein.
  • crude palm oil contains about 99% w/w oil because almost all of the non-oil solids have been removed.
  • the non-hydratable phosphorus content of the palm fruit extract e.g. the pressed palm fruit extract
  • the non-hydratable phosphorus content may be considered to be equivalent to non-hydratable phospholipids.
  • the non- hydratable phosphorus in non-hydratable phospholipids content of the palm fruit extract may be less than 45 ppm, preferably less than 30 ppm.
  • the incubation of the admixed at least one enzyme(s) and the at least one palm fruit or portion thereof or palm fruit extract in accordance with the present invention may be carried out at about 40 °C to about 100 °C.
  • the incubation of the admixed at least one enzyme(s) and the palm fruit or portion thereof or palm fruit extract may be carried out at about 45 °C to about 95 °C, suitably at about 50 °C to about 95 °C; more suitably at about 50 °C to about 90 °C; and even more suitably at about 55 °C to about 85 °C.
  • the admixture may be incubated at above about 65 °C, preferably about 70 °C.
  • the admixture may be incubated between about 70 °C to about 90 °C; preferable at about 75 °C to about 80 °C; and even more suitably about 80 °C.
  • the admixture may be incubated at above about 55 °C, preferably about 60 °C.
  • the length of time necessary to achieve the effects will be somewhat dependent on the temperature at which the admixture of the enzyme composition and a palm fruit or a portion thereof or a palm fruit extract are incubated.
  • the incubation of the admixed enzyme composition and the at least one palm fruit or portion thereof or palm fruit extract may be carried out for at least about 30 minutes to about 8 hours.
  • the admixture may be incubated for about 4 hours.
  • the water content (w/w) of the palm fruit or portion thereof or palm fruit liquid or sludge may be determined using the following method: by evaporation at 160 °C using a ML50 Moisture analyzer (A&D Company Limited (Tokyo, Japan)) - in which the water readout is monitored until the change in weight is less than 0.1 %/minute and the % water is read. Moisture can also be analyzed by Moisture Air-Oven Methods, AACC International Method 44-15.02.
  • Amino acids are referred to herein using the name of the amino acid, the three letter abbreviation or the single letter abbreviation.
  • protein includes proteins, polypeptides, and peptides.
  • amino acid sequence is the sequence of amino acids as arrayed within a protein molecule. As such, the term may be used synonymously with the term “polypeptide” and/or the term “protein”. In some instances, the term “amino acid sequence” is synonymous with the term “peptide”. In some instances, the term “amino acid sequence” is synonymous with the term “enzyme”.
  • protein and polypeptide are used interchangeably herein. In the present disclosure and claims, the conventional one- letter and three-letter codes for amino acid residues may be used.
  • the enzyme composition for use in the present invention comprises cellulase activity.
  • the cellulase activity according to the present invention may be an endoglucanase (e.g. a ⁇ -glucanase) activity.
  • the enzyme composition in addition to comprising cellulase activity, comprises one or more of the following enzyme activities: mannanase activity, pectinase activity, and a combination thereof.
  • the enzyme composition for use in the present methods may be a crude or purified extract of a Trichoderma reseei fermentate.
  • the enzyme composition may (in addition to having a cellulase (e.g. an endoglucanase (e.g. a ⁇ -glucanase)), activity further comprise one or more of the activities selected from the group consisting of: a mannanase activity, a pectinase activity, a xylanase activity, a glucuronidase activity, a galactanase activity, and combinations thereof.
  • the enzyme composition comprises endoglucanase (e.g.
  • the enzyme composition may comprise endoglucanase (e.g. a ⁇ -glucanase) activity and pectinase activity.
  • cellulases or “cellulolytic enzymes”, as used herein, are understood as comprising endo-glucanase (EC 3.2.1.4) activity. In one embodiment the enzyme
  • composition used in accordance with the present invention is an endoglucanase (EC
  • the cellulases may comprise a carbohydrate-binding module (CBM) which enhances the binding of the enzyme to a cellulose-containing fiber and increases the efficacy of the catalytic active part of the enzyme.
  • CBM is defined as contiguous amino acid sequence within a carbohydrate- active enzyme with a discrete fold having carbohydrate-binding activity.
  • the cellulases or cellulolytic enzymes may be a cellulolytic preparation as defined in U.S. provisional patent application no. 60/941 ,251.
  • the enzyme composition is a cellulase enzyme, such as one derived from Trichoderma reesei.
  • the cellulolytic activity may, in some embodiments, be derived from a fungal source, such as a strain of the genus Trichoderma, such as a strain of
  • Trichoderma reesei or a strain of the genus Humicola, such as a strain of Humicola insolens.
  • Endoglucanases catalyze endo-hydrolysis of 1 ,4-beta-D-glycosidic linkages in cellulose, cellulose derivatives (such as carboxy methyl cellulose and hydroxy ethyl cellulose), lichenin, beta-1 ,4 bonds in mixed beta-1 ,3 glucans such as cereal beta-D- glucans or xyloglucans and other plant material containing cellulosic parts.
  • the authorized name is endo-1 ,4-beta-D-glucan 4-glucano hydrolase, but the abbreviated term
  • endoglucanase is used in the present specification. Endoglucanase activity may be determined using carboxymethyl cellulose (CMC) hydrolysis according to the procedure of Ghose ((1987), Pure and Appl. Chem. 59: 257-268).
  • CMC carboxymethyl cellulose
  • endoglucanases may be derived from a strain of the genus Trichoderma, such as a strain of Trichoderma reesei; a strain of the genus Humicola, such as a strain of Humicola insolens; or a strain of Chrysosporium, preferably a strain of Chrysosporium lucknowense.
  • the cellulase for use in the present invention may be a Chrysosporium lucknowense cellulase available from Dyadic International USA Inc.
  • the enzyme composition for use in the methods and/or uses of the present invention may be the product of expression of one or more enzyme(s) in a suitable host cell (e.g. a fermentation product).
  • a suitable host cell e.g. a fermentation product
  • the enzyme composition comprising any one or more of the activities indicated in the foregoing embodiment may be obtainable (e.g. obtained) from Trichoderma, preferably from Trichoderma reesei.
  • a suitable enzyme composition for use in the methods and/or uses in accordance with the present invention may be or may comprise LAMINEX® BG2
  • LAMINEX® BG2 is a commercial preparation of an enzyme complex hydrolyzing beta-glucans and related carbohydrates. It is produced by fermentation with a selected strain of Trichoderma reesei.
  • LAMINEX® BG2 is composed of: water 59 - 71 % (w/w); cellulase 15 - 20 % (w/w); sorbitol
  • the enzyme composition may be a fermentation of Penicillum funiculosum in combination with fermentation from Trichoderma, e.g. Trichoderma reesei.
  • the cellulase according to the present invention may be LAMI EX® Super 3G (DuPont Industrial Biosciences).
  • LAMINEX® Super 3G is a
  • LAMINEX® Super 3G is produced by fermentation with selected strains of Trichoderma reesei and Penicillum funiculosum. LAMINEX® Super 3G is composed of: water 75.8 - 80.8 % (w/w); cellulase 15 - 20 % (w/w); sorbitol 6.50 % (w/w); sodium chloride 2.20 % (w/w); and sodium benzoate 0.50 % (w/w).
  • the enzyme composition comprising cellulase is preferably one which solubilises as much sediment as possible.
  • the enzyme composition comprising cellulase is preferably one which comprises mannanase activity.
  • the enzyme composition preferably comprises cellulase activity together with mannanase activity, in which case the enzyme composition comprises a minimum level of mannanase activity which when added to the substrate gives a mannanase concentration of at least 200 MVR kg substrate.
  • the cellulase composition may comprise mannanase side activity. Where the mannanase activity is a side activity, it must represent at least 200 MVR/kg substrate. Alternatively, a separate mannanase enzyme may be added to a cellulase composition to ensure at least 200 MVR/kg substrate mannanase activity is present in the substrate.
  • the enzyme composition may comprise a xylanase.
  • the xylanase is of microbial origin, such as of fungal origin (e.g., Trichoderma, Meripilus, Humicola, Aspergillus, and Fusarium) or from a bacterium (e.g., Bacillus).
  • the xylanase is derived from a filamentous fungus, preferably derived from a strain of Aspergillus, such as Aspergillus aculeatus; or a strain of Humicola, preferably Humicola lanuginosa.
  • the xylanase may preferably be an endo-1 ,4-beta-xylanase.
  • Examples of commercial xylanases include GRINDAMYLTM POWERBAKE® 930 from Danisco A S, Denmark or SHEARZYMETM and BIOFEED WHEATTM from Novozymes A/S, Denmark.
  • the enzyme composition may comprise a glucuronidase.
  • the glucuronidase may be one or more selected from: a 1 ,2-alpha-glucuronidase (E.C. 3.2.1.131), an alpha-glucuronidase (E.C. 3.2.1.139), a beta-glucuronidase (E.C. 3.2.1.31), a glucuronosyl-disulfoglucosamine glucuronidase (E.C. 3.2.1.56) or any combination thereof.
  • the term "beta-glucuronidase” is synonymous with "beta-glucuronide glucuronohydrolase".
  • the glucuronidase may be a 1 ,2-alpha- glucuronidase (E.C. 3.2.1.131).
  • the glucuronidase may be an alpha- glucuronidase (E.C. 3.2.1.139).
  • the glucuronidase may be a beta- glucuronidase (E.C. 3.2.1.31 ).
  • the glucuronidase may be a glucuronosyldisulfoglucosamine (E.C. 3.2.1.56).
  • the enzyme composition may comprise a galactanase.
  • the galactanase may be selected from an exo-galactanase (E.C. 3.2.1.23) or an endo- galactanase (E.C. 3.2.1.89) for example, an arabinogalactan endo-1 , 4-beta-galactosidase or a galactan endo-beta-1 ,3-galactanase (E.C. 3.2.1.181 ).
  • Arabinogalactan endo-1 ,4-beta- galactosidase catalyzes the endohydrolysis of 1 ,4-D-galactosidic linkages in
  • xylanase refers to an enzyme that is able to hydrolyze the beta-1 ,4 glycosyl bond in non-terminal beta-D- xylopyranosyl-1 ,4-beta-D-xylopyranosyl units of xylan or arabinoxylan.
  • Xylanases can be derived from a variety of organisms, including plant, fungal (e.g. species of Aspergillus, Penicillium, Disporotrichum, Neurospora, Fusarium, Humicola, Trichoderma, Geosmithia, Talaromyces) or bacterial species (e.g. species of Bacillus, Aeromonas, Streptomyces, Nocardiopsis, Thermomyces) (see International Patent
  • the xylanase used in the methods described herein is an enzyme classified as EC 3.2.1.8.
  • the official name is endo-1 ,4-beta-xylanase.
  • the systematic name is 1 ,4-beta-D-xylan xylanohydrolase.
  • endo-(1-4)-beta- xylanase (1-4)-beta-xylan 4-xylanohydrolase; endo-1 ,4-xylanase; xylanase; beta-1 ,4- xylanase; endo-1 ,4-xylanase; endo-beta-1 ,4-xylanase; endo-1 ,4-beta-D- xylanase; 1 ,4-beta- xylan xylanohydrolase; beta-xylanase; beta-1 ,4-xylan xylanohydrolase; endo-1 , 4-beta- xylanase; beta-D-xylanase.
  • the reaction catalyzed is the endohydrolysis of 1 ,4-beta-D- xylanase;
  • the mannanase for use in the present methods may be any commercially available mannanase.
  • the mannanase may be an endo-1 ,4- -D-mannanase (classified as E.C. 3.2.1.78) or a ⁇ -mannosidase (classified as E.C. 3.2.1.25).
  • the mannanase is preferably an endomannanase, such as an endo-1 , 4- ⁇ - D- mannanase.
  • the classification for an endo-1 ,4 ⁇ -D-mannanase ( ⁇ -mannanase) is E.C.
  • the enzyme composition comprises a ⁇ -mannanase (E.C. 3.2.1.78) from Bacillus. In one embodiment, the enzyme composition comprises a ⁇ - mannanase (E.C. 3.2.1.78) from Bacillus lentus or Bacillus subtilis or Bacillus licheniformis. In a further embodiment, the enzyme composition may comprise a mannanase (e.g. E.C. 3.2.1.78) produced in Trichoderma, e.g. Trichoderma reesei. In another embodiment, the enzyme composition may comprise MANNASTAR® 375 (DuPont Industrial Biosciences).
  • the enzyme composition comprises a ⁇ -mannanase (E.C.
  • the enzyme composition comprises HEMICELL®-W (a commercial product sold by ChemGen Corp. comprising ⁇ -Mannanase (EC 3.2.1.78) from Bacillus lentus and a xylanase (EC 3.2.1.8) from Trichoderma longibrachiatum).
  • the enzyme composition comprises a ⁇ -mannanase (E.C.
  • the enzyme composition may comprise ZYMANASE® (a commercial product sold by ChemGen Corp. comprising a ⁇ - Mannanase (EC 3.2.1.78) and a ⁇ -glucanase.
  • the enzyme composition may comprise CTCZYME® - a product sold by CTC BIO Inc., and comprising a ⁇ - Mannanase (EC 3.2.1.78) from Bacillus licheniformis (B.
  • the enzyme composition may comprise a mannanase taught in US Patent No. 7,846,705.
  • the enzyme composition is suitably a thermostable enzyme composition.
  • one or more of the enzyme(s) used in the present methods and/or uses are thermostable enzyme(s).
  • the enzyme or thermostable enzyme is not a genetically modified enzyme.
  • thermostability is the ability of an enzyme to resist irreversible inactivation (usually by denaturation) at a relatively high temperature. This means that the enzyme retains a specified amount of enzymatic activity after exposure to an identified temperature over a given period of time.
  • enzyme samples maybe incubated without substrate for a defined period of time (e.g. 10 min or 1 to 30 min) at an elevated temperature compared to the temperature at which the enzyme is stable for a longer time (days). Following the incubation at elevated temperature the enzyme sample is assayed for residual activity at the permissive temperature of e.g. 30 °C (alternatively 25-50 °C or even up to 70 °C). Residual activity is calculated as relative to a sample of the enzyme that has not been incubated at the elevated temperature.
  • Thermostability can also be measured as enzyme inactivation as function of temperature. Enzyme samples are incubated without substrate for a defined period of time (e.g. 10 min or 1 to 30 min) at various temperatures and following incubation assayed for residual activity at the permissive temperature of e.g. 30 °C (alternatively 25-70 °C or even higher). Residual activity at each temperature is calculated as relative to a sample of the enzyme that has not been incubated at the elevated temperature. The resulting thermal denaturation profile (temperature versus residual activity) can be used to calculate the temperature at which 50% residual activity is obtained. This value is defined as the Tm value. Even further, thermostability can be measured as enzyme inactivation as function of time.
  • enzyme samples are incubated without substrate at a defined elevated temperature (e.g. 76 °C) for various time periods (e.g. between 10 sec and 30 min) and following incubation assayed for residual activity at the permissive temperature of e.g. 30 °C (alternatively 25-70 °C or even higher). Residual activity at each temperature is calculated as relative to an enzyme sample that has not been incubated at the elevated temperature.
  • the resulting inactivation profile time versus residual activity
  • T1/2 time at which 50 % residual activity is obtained. This is usually given as T1/2.
  • thermostability is assessed by use of the "Assay for measurement of thermostability” as taught herein.
  • the thermostability of an enzyme for use in accordance with the present invention may be determined using the "Assay for measurement of thermostability” (see below).
  • thermoactivity is enzyme activity as a function of temperature.
  • samples may be incubated (assayed) for the period of time defined by the assay at various temperatures in the presence of substrate. Enzyme activity is obtained during or immediately after incubation as defined by the assay (e.g. reading an OD-value which reflects the amount of formed reaction product).
  • the temperature at which the highest activity is obtained is the temperature optimum of the enzyme at the given assay conditions.
  • the activity obtained at each temperature can be calculated relative to the activity obtained at optimum temperature. This will provide a temperature profile for the enzyme at the given assay conditions.
  • the thermal denaturation profiles of the enzyme is measured by diluting and pre-incubating the enzyme samples in 25 mM acetate buffer, pH 4.5 for 10 min at varying temperatures (60, 65, 70, 75, 80, 85 and 90°C, respectively) and subsequently measuring the residual activity of the enzyme when tested in the "Beta-Glucanase Activity Assay" described herein.
  • activity measured without pre-incubation is set to 100 % and the residual activity of an enzyme at each temperature is calculated as relative to this.
  • Tm value is calculated from the thermal denaturation profiles as the temperature at which 50 % residual activity is obtained.
  • an enzyme is considered to be thermostable in accordance with the present method if it has a Tm value of more than 70°C, wherein the Tm value is the temperature at which 50% residual activity is obtained after 10 min incubation. This Tm value may be measured in accordance with the assay for measurement of thermostability as taught herein.
  • an enzyme is considered to be thermostable in accordance with the present method if it has a Tm value of more than 75°C, wherein the Tm value is the temperature at which 50% residual activity is obtained after 10 min incubation. This Tm value may be measured in accordance with the assay for measurement of thermostability as taught herein.
  • an enzyme is considered to be thermostable in accordance with the present method if it has a Tm value of more than 80°C, wherein the Tm value is the temperature at which 50% residual activity is obtained after 10 min incubation. This Tm value may be measured in accordance with the assay for measurement of thermostability as taught herein.
  • the thermostable enzymes described herein possessing residual activity post heat treatment may be used in subsequent processes (e.g., for use in a biorefinery application).
  • the enzyme according to the present methods and/or uses is not CELLUCLAST® (by Novozymes, A S).
  • the enzyme according to the present methods and/or uses does not comprise pectinase activity.
  • the enzyme or thermostable enzyme for use in the methods and/or uses described herein may be immobilized.
  • immobilized means that the enzyme or enzyme is fixed in position and its movement impeded but the activity of the enzyme or thermostable enzyme is not substantially altered by such immobilization.
  • an immobilized enzyme or thermostable enzyme may retain at least 50% of its activity when compared to a non-immobilized enzyme or thermostable enzyme.
  • it may retain at least about 50%, 60%, 70%, 80%, 90% or 95% of its activity when compared to a non-immobilized enzyme or thermostable enzyme.
  • An "immobilized” enzyme or thermostable enzyme may be fixed to a surface. This may be achieved by any known means within the art which do not substantially alter the activity of the enzyme or thermostable enzyme.
  • the enzyme or thermostable enzyme may be immobilized by cross-linking (e.g. cross-linking to a surface).
  • the enzyme may be cross-linked with glutaraldehyde in order to improve the enzymes thermostability.
  • glutaraldehyde for example, see the teachings of Schmid et al., Adv. Biochem Eng. 12, p 41 ,118 (1979) and European Patent No. EP0575323B1.
  • the assay of cellulase activity is based on the enzymatic hydrolysis of the 1 ,4-p-D-glucosidic bonds in carboxymethylcellulose (CM- Cellulose 4M, Megazyme Ltd) a -1 ,4-glucan.
  • the enzyme is diluted in ddH 2 0 and 0,25 ml_ enzyme solution added to 1 ,75 ml_ substrate (1 ,5% CMC in 0.2M sodium acetate buffer, pH 5.0) at 50 °C. After 10 min of incubation a 2 ml_ 1% 3,5-Dinitrosalicylic acid (DNS) solution is added and the sample is placed in boiling water bath for 5 min.
  • DDS 3,5-Dinitrosalicylic acid
  • the products of the reaction are determined colorimetrically at 540 nm by measuring the resulting increase in reducing groups reacting with the DNS.
  • Enzyme activity is calculated from the relationship between the concentration of reducing groups, as glucose equivalents, and absorbance using a glucose standard in the range 0.125-0.5 mg/mL.
  • One unit of cellulase activity is defined as the amount of enzyme which produces 1 mole glucose equivalents per minute under assay conditions.
  • the cellulase in accordance with the present method is a cellulase which reduces the amount of dry sediment (dry matter) by at least 20% when 25000 CMC-DNS/kg substrate is added to a palm fruit, a portion thereof or a palm fruit extract and incubated for 1 hr at 50°C and the sludge dry matter is analysed by the following method: After incubation the sample was placed in at water bath at 95 degrees for 10 minutes to stop the enzyme reaction, and transferred to a tarred 50-mL centrifuge tube. The sample was centrifuged at 4180 rcf and 60 °C for 10 minutes. The upper oil layer was removed, and remaining water phase was discharged.
  • hydrocolloid solution (0,5% GRINDSTED® GUAR 250 (DuPont Nutrition Biosciences) pH 6.7 or 1.4% GRINDSTED® Pectin SY200 (DuPont Nutrition Biosciences) pH 4 in Citric acid-Sodium phosphate buffer) and incubated 19 hours at 40 °C.
  • the hydrocolloid is cleaved by the enzyme to oligosaccharides, thereby creating a drop in viscosity of the solution.
  • samples are tempered for 20 minutes on ice before measuring viscosity at 0 °C using a Viscoman pipette (Gilson, Inc., USA).
  • the viscosity reduction is calculated as the viscosity of a sample with addition of enzyme relative to viscosity of sample without enzyme.
  • the viscosity reduction is plotted against LN ( ⁇ _ dosage in substrate) and should be linear within relative viscosity of 0.1 to 0.85.
  • Activity of the sample in U/g is calculated using the regression line.
  • Pectinase viscosity reduction (PVR) and Mannanase viscosity reduction (MVR) units are defined as the amount of enzyme that will degrade the hydrocolloid substrate solution to a 50% (0.5) viscosity reduction in 19 hours of incubation at 40 ° C.
  • the enzyme composition comprises mannanase
  • the enzyme composition comprises a minimum level of mannanase activity which when added to the substrate will give a mannanase concentration of at least about 200 VR/kg substrate.
  • the enzyme composition comprises pectinase
  • the enzyme composition comprises a minimum level of pectinase activity which when added to the substrate will give a mannanase concentration of at least about 9 PVR/kg substrate.
  • the enzyme composition comprises low or no protease. In other words preferably there is no or only very low levels of protease activity in the reaction admixture during incubation.
  • PROTEASE ACTIVITY PU
  • PROTEASE ACTIVITY PU
  • the azocasein assay is based on hydrolyses of the azocasein which releases the azo dyed peptide in the supernatant where it is detected at 450 nm. These peptides cannot precipitate by the addition of acid, as against non hydrolysed azocasein, which precipitates.
  • Substrate 0,25% Azocasein (Sigma A2765; Sigma-Aldrich, St. Louis, MO, USA) dissolved in 50 mM sodium-citrate buffer pH 6.
  • the activity of the enzyme sample is measured based on a calibration curve obtained by analyzing different dilutions of a commercial protease, PROTEX® 14L (Standardized to 150 PU/mL) and construction of a calibration curve of OD 450 as a function of PU/g.
  • the enzyme composition preferably has not more than about 0.1
  • the enzyme composition preferably has not more than about 0.04 PU/mL.
  • assay buffer 0.1 M NaAc, pH 5.0
  • enzyme solution 25 pL, 50 pL, 75 pL and 100 pL of enzyme solution and the mixtures are equilibrated at 40.0 °C for 5 minutes.
  • One XylaZyme tablet (Megazyme International cat no. T-XYZ100, Wicklow, Ireland) (e.g. containing AZCL-arabinoxylan (wheat)) is added to each test tube and the test tubes must not be stirred. After exactly 10 minutes incubation 10 mL stop solution (1% (w/v) Tris(hydroxymethyl)- aminomethane) is added. The test tubes are stirred and the solutions are filtered through Whatman No. 1 filter paper.
  • the absorbance at 590 nm of standard and test samples is measured against a blank sample without enzyme.
  • the concentrations of standard and sample enzymes are adjusted so that the optical densities (OD) at 590 nm are within the range 0.2-1.1.
  • the Standard enzyme is xylanase from Aspergillus niger, Megazyme cat. no. E-XYAN4.
  • the OD 590 's for standard and test enzymes are plotted against the volumes of enzyme solution added. The best curve fit is found using linear regression.
  • the volumes of standard (V st ) and test enzymes (V t ) corresponding to an OD 590 of 0.7 are calculated.
  • V st volume of standard enzyme read on x-axis, ⁇ .
  • An enzyme is a xylanase for use in the present methods if in the Xylanase Activity Assay herein it has at least 100 Units/mL
  • the one or more enzyme(s) for use in the methods and/or uses may be dosed at predetermined amounts when treating the palm fruit or a portion thereof or palm fruit extract.
  • the one or more enzyme(s) for use in the methods and/or uses may be dosed at an amount which reduces the viscosity in palm fruit extract by at least 10%.
  • the one or more enzyme(s) may be dosed at 0.5 to 500 mg/kg palm fruit or extract.
  • the one or more enzyme(s) may be dosed at 1 to 200 mg/kg palm fruit or extract.
  • the one or more enzyme(s) may be dosed at 1 to 100 mg/kg palm fruit or extract.
  • the one or more enzyme(s) may be dosed at 1 to 50 mg/kg palm fruit or extract.
  • the one or more enzyme(s) may be dosed at 1 to 10 mg/kg palm fruit or extract.
  • the host organism can be a prokaryotic or a eukaryotic organism.
  • the at least one enzyme may be obtainable (e.g. obtained) from any source.
  • the at least one enzyme may be a recombinant enzyme, for example an enzyme that is heterologous to the cell in which it is expressed. In other embodiments the enzyme may be native to the cell in which it is expressed.
  • the one or more enzyme(s) is not obtainable (e.g. obtained) from a Trichoderma (e.g. Trichoderma reesei) host cell.
  • the host cell may be any Bacillus cell.
  • said Bacillus host cell being from one of the following species: Bacillus licheniformis; B. subtilis; B. al alophilus; B. amyloliquefaciens; B. circulans; B. clausii; B. coagulans; B. firmus; B. lautus; B. lentus; B. megaterium; B. pumilus or B. stearothermophilus.
  • the host cell may a fungal host cell.
  • the host cell may be any a Trichoderma, Meripilus, Humicola, Aspergillus, Fusarium or Chrysosporium host cell.
  • the host cell may be a protease deficient or protease minus strain and/or an a- amylase deficient or a-amylase minus strain.
  • heterologous means a sequence derived from a separate genetic source or species.
  • a heterologous sequence is a non-host sequence, a modified sequence, a sequence from a different host cell strain, or a homologous sequence from a different chromosomal location of the host cell.
  • a "homologous”, as used herein, sequence is a sequence that is found in the same genetic source or species i.e. it is naturally occurring in the relevant species of host cell.
  • an enzyme for use in the methods and/or uses taught herein may be obtained by operably linking a nucleotide sequence encoding same to a regulatory sequence which is capable of providing for the expression of the nucleotide sequence, such as by the chosen host cell (such as a B. licheniformis cell).
  • a vector comprising the nucleotide sequence is operably linked to such a regulatory sequence, i.e. the vector is an expression vector, may be used.
  • operably linked refers to a juxtaposition wherein the components described are in a relationship permitting them to function in their intended manner.
  • a regulatory sequence "operably linked” to a coding sequence is ligated in such a way that expression of the coding sequence is achieved under conditions compatible with the control sequences.
  • regulatory sequences includes promoters and enhancers and other expression regulation signals.
  • promoter as used herein, is used in the normal sense of the art, e.g. an RNA polymerase binding site.
  • nucleotide sequence encoding the enzyme having the specific properties as defined herein may also be achieved by the selection of regulatory regions, e.g. promoter, secretion leader and terminator regions that are not regulatory regions for the nucleotide sequence encoding the enzyme in nature.
  • the nucleotide sequence may be operably linked to at least a promoter.
  • the promoter sequence may be heterologous or homologous to the sequence encoding any one of the enzymes for use in the methods or uses taught herein.
  • the promoter sequence may be any promoter sequence capable of directing expression of an enzyme in the host cell of choice.
  • the promoter sequence may be homologous to a Bacillus species, for example B. licheniformis.
  • the promoter sequence is homologous to the host cell of choice.
  • the promoter may be homologous to a Geosmithia species, for example Geosmithia emersonii.
  • the promoter sequence may be homologous to the host cell. "Homologous to the host cell", as used herein, means originating within the host organism; i.e. a promoter sequence which is found naturally in the host organism.
  • the promoter sequence may be selected from the group consisting of a nucleotide sequence encoding: an a-amylase promoter, a protease promoter, a subtilisin promoter, a glutamic acid-specific protease promoter and a levansucrase promoter.
  • the promoter sequence may be a nucleotide sequence encoding: the LAT (e.g. the alpha-amylase promoter from B. licheniformis, also known as AmyL), AprL (e.g. subtilisin Carlsberg promoter), EndoGluC (e.g. the glutamic-acid specific promoter from B. licheniformis), AmyQ (e.g. the alpha amylase promoter from B. amyloliquefaciens alpha-amylase promoter) and SacB (e.g. the B. subtilis levansucrase promoter).
  • LAT e.g. the alpha-amylase promoter from B. licheniformis, also known as AmyL
  • AprL e.g. subtilisin Carlsberg promoter
  • EndoGluC e.g. the glutamic-acid specific promoter from B. licheniformis
  • AmyQ e.g. the alpha amylase promoter from B. amyl
  • promoters suitable for directing the transcription of a nucleic acid sequence may include: the promoter of the Bacillus lentus alkaline protease gene (aprH), ; the promoter of the Bacillus subtilis alpha-amylase gene (amyE); the promoter of the Bacillus stearothermophilus maltogenic amylase gene (amyM); the promoter of the Bacillus licheniformis penicillinase gene (penP); the promoters of the Bacillus subtilis xylA and xylB genes; and/or the promoter of the Bacillus thuringiensis subsp. tenebrionis CrylllA gene.
  • the enzyme produced by a host cell by expression of the nucleotide sequence encoding the enzyme may be secreted or may be contained intraceliularly depending on the sequence and/or the vector used.
  • a signal sequence may be used to direct secretion of the coding sequences through a particular cell membrane.
  • the signal sequences may be natural or foreign to the coding sequence of the enzymes.
  • the signal peptide coding sequence may be obtained from an amylase or protease gene from a Bacillus species, preferably from Bacillus licheniformis.
  • Suitable signal peptide coding sequences may be obtained from one or more of the following genes: maltogenic a-amylase gene, subtilisin gene, beta-lactamase gene, neutral protease gene, and/or prsA gene.
  • a nucleotide sequence encoding a signal peptide may be operably linked to a nucleotide sequence encoding any one of the enzymes disclosed herein.
  • the enzyme may be expressed in a host cell as defined herein as a fusion protein.
  • expression vector means a construct capable of in vivo or in vitro expression.
  • the expression vector is incorporated in the genome of the organism, such as a B. licheniformis host.
  • incorporated as used herein, preferably covers stable incorporation into the genome.
  • the nucleotide sequence encoding an enzyme as defined herein may be present in a vector, in which the nucleotide sequence is operably linked to regulatory sequences such that the regulatory sequences are capable of providing the expression of the nucleotide sequence by a suitable host organism (such as B. licheniformis), i.e. the vector is an expression vector.
  • a suitable host organism such as B. licheniformis
  • the vectors may be transformed into a suitable host cell as described above to provide for expression of a polypeptide having cellulase activity as defined herein.
  • the choice of vector e.g. plasmid, cosmid, virus or phage vector, genomic insert, will often depend on the host cell into which it is to be introduced.
  • the present methods may use other forms of expression vectors which serve equivalent functions and which are, or become, known in the art.
  • the vector Once transformed into the host cell of choice, the vector may replicate and function independently of the host cell's genome, or may integrate into the genome itself.
  • the vectors may contain one or more selectable marker genes - such as a gene which confers antibiotic resistance e.g. ampicillin, kanamycin, chloramphenicol or tetracycline resistance.
  • Vectors may be used in vitro, for example for the production of RNA or used to transfect or transform a host cell.
  • the vector may further comprise a nucleotide sequence enabling the vector to replicate in the host cell in question. Examples of such sequences are the origins of replication of plasmids pUC19, pACYC177, pUB1 10, pE194, pAMB1 and plJ702.
  • the enzyme is a recovered/isolated enzyme.
  • the enzyme produced may be in an isolated form.
  • the enzyme may be in a purified form.
  • purified means that the sequence is in a relatively pure state - e.g. at least about 51% pure, or at least about 75%, or at least about 80%, or at least about 90% pure, or at least about 95% pure or at least about 98% pure.
  • the methods and/or uses described herein have many advantages over methods and/or uses taught in the prior art.
  • the enzyme composition(s) for use in the present methods is/are advantageously able to decrease oil in sediment, decrease viscosity of the oil obtained from the palm fruit or portion thereof or palm fruit extract (e.g. pressed palm fruit extract), improve palm oil yields, and/or increase fermentable sugars in the aqueous phase.
  • the methods and uses taught herein make it possible to isolate a heavy sediment phase.
  • the thus isolated heavy phase has a low water binding capacity making it easy to dry.
  • This has advantages with regard to downstream processing of this waste-stream. For example, it can be burnt to generate steam for the plant.
  • the method and/or uses taught herein also result in increased palm oil yields during palm oil processing.
  • the enzyme treatment is of the pressed palm oil liquid and occurs in or just before the clarifier. This has additional advantageous properties, for example one or more of the following:
  • a further advantage taught herein is the aqueous phase of the centrifuged enzyme treated pressed palm oil liquid or palm fruit is enriched in fermentable sugars in comparison to waste water from palm oil mills not utilizing the enzymatic treatment of the present methods.
  • this renders the aqueous phase suitable as a fermentation medium (e.g. together with empty fruit bunches), e.g. for the production of bioethanol.
  • a fermentation medium e.g. together with empty fruit bunches
  • the water in the aqueous phase may be recycled back into the process before the clarification tank.
  • one advantage of using the present method is to reduce the amount of POME in the processing of palm fruit.
  • thermostable enzyme e.g. a thermostable enzyme in palm fruit processing.
  • the thermostable enzyme is able to function at the high temperatures used in palm fruit processing. This allows the enzymatic solution to be directly applied in current processes with minimal investment in additional or new equipment (for example, a low temperature incubation tank) or disruption of existing technologies.
  • the use of thermostable enzymes has the advantage that the palm fruit/palm fruit extract does not need to be cooled post-high temperature processing (e.g. sterilisation of the fruit bunch for instance) in order for the enzymes to function.
  • the thermostable enzyme can be used directly in high-temperature environments, e.g. in the digester.
  • Cooling and often additional reheating thereafter
  • Cooling is generally undesirable as it leads to a less efficient process and/or additional energy consumption.
  • such cooling may be mediated by addition of chilled water.
  • POME palm oil mill effluent, Industrial Processes & The Environment (Handbook No.3) Crude Palm Oil Industry; Department of Environment, Ministry of Science, Technology, and the Environment, Malaysia, (1999), Mohd. Ishak Thani, Rahani Hussin, Wan Ramlah Bt.
  • cooling and reheating steps can actually prolong the overall time that pressed palm oil extract is exposed to higher temperatures, which can have an adverse effect on oil quality due to increased rates of free fatty acid formation at higher temperatures.
  • the crude palm oil produced in accordance with the present methods particularly when a thermostable enzyme is used, may have a low concentration of free fatty acids.
  • cooling and reheating e.g. oscillating
  • a further advantage is that oil obtainable (e.g. obtained) from the present methods and uses separates more easily and faster from the pressed palm liquid thus reducing the amount of oil in the waste stream. This advantageously allows production capacity to be increased.
  • Another advantage is that the sludge contains less oil so that the remaining oil can be more easily separated in the separator.
  • a method of improving palm oil yields comprises:
  • a use of an enzyme composition comprising cellulase activity in combination with a palm fruit or a portion thereof or a palm fruit liquid, wherein said palm fruit or portion thereof or palm fruit liquid when admixed with the enzyme composition comprises at most 40% water content w/w in the manufacture of palm oil for improving palm oil yield, for improving separation of palm oil from the sludge phase, for producing an aqueous phase with improved fermentable sugars, or for improving the speed of oil separation.
  • a method is provided according to the first preferred embodiment or second preferred embodiment wherein said palm fruit or portion thereof or palm fruit liquid when admixed comprises at most 38% water content w/w, suitably at most 35% water content w/w, suitably at most 30% water content w/w.
  • a method is provided according to any one of the previous preferred embodiments wherein the palm fruit liquid is a pressed palm fruit liquid.
  • a method is provided according to any one of the preceding preferred embodiments wherein the oil is separated by gravity (e.g. by clarification).
  • a method is provided according to any one of the preceding preferred embodiments wherein the oil is separated by centrifugation either instead of gravitation separation or in addition to separation by gravity.
  • a method is provided according to the sixth preferred embodiment wherein the separation (e.g. centrifugation) results in a triple phase composition comprising an oil layer, an aqueous layer and a substantially solid sediment (or sludge) layer.
  • the separation e.g. centrifugation
  • a method is provided according to the seventh preferred embodiment wherein the aqueous phase is enriched in soluble fermentable sugars.
  • a method is provided according to any one of the preceding preferred embodiments wherein said enzyme composition in addition to comprising cellulase activity comprises one or more of the following enzyme activities: mannanase and pectinase.
  • a method is provided according to any one of the preceding preferred embodiments wherein said enzyme composition comprises low or no protease.
  • a method is provided according to any one of the preceding preferred embodiments wherein the enzyme composition is a crude or purified extract of a Trichoderma reesei fermentate.
  • a method is provided according to any one of the preceding preferred embodiments wherein there is no or only minimal agitation during the incubation stage.
  • a method is provided according to any one of the preceding preferred embodiments wherein the cellulase in one which reduces the amount of dry sediment (sludge dry matter) by at least 20% when 25000 CMC-DNS/kg substrate is added to a palm fruit, a portion thereof or a palm fruit extract and incubated for 1 hr at 50°C.
  • a method is provided according to any one of the ninth, tenth, eleventh, twelfth, and thirteenth preferred embodiments wherein when the enzyme composition comprises mannanase, the enzyme composition comprises a minimum level of mannanase activity which when added to the substrate give a mannanase concentration of at least 200 MVR/kg substrate.
  • a palm oil phase, a sludge phase or an aqueous phase obtainable by the method according to any one of the preceding preferred embodiments.
  • a use of an aqueous phase obtained by the method according to any one of the preceding preferred embodiments as a fermentation medium is also provided.
  • a method for producing a fermentation product comprising fermenting a feedstock comprising said aqueous phase obtainable (preferably obtained) by the method according to any one of the preceding preferred embodiments and recovering said fermentation product.
  • a method is provided according to the seventeenth preferred embodiment wherein said feedstock further comprises empty palm fruit bunches or processed empty palm fruit bunches.
  • a method is provided according to the seventeenth or eighteenth preferred embodiments wherein said fermentation product is a compound selected from the group consisting of: an alcohol, an organic acid, an antibiotic, an antimicrobial, bioinsecticide, a solvent, and a polyhydroxyalkanoate.
  • a method is provided according to any one of the seventeenth, eighteenth or nineteenth preferred embodiments wherein the feedstock is subjected to one or more processing steps selected from the group consisting of: milling, cooking and/or saccharification.
  • a method provided according to the nineteenth or twentieth preferred embodiments wherein the alcohol is a biofuel (e.g. an ethanol, a butanol or a combination thereof).
  • a biofuel e.g. an ethanol, a butanol or a combination thereof.
  • polyacrylamide "mg/mL” is milligrams per milliliters.
  • LAMINEX® 750 (DuPont Industrial Biosciences) A03193G190 batch 4861668300, 2037 CMC-DNS/g, 20 MVU/g.
  • LAMINEX® 750 is a commercial preparation of an enzyme composition comprising: water 85 - 90 % (w/w); endo-1 ,3(4)-beta-glucanase 10 - 15 % (w/w), and sodium benzoate 0.25 % (w/w).
  • LAMINEX® BG2 batch no, 4902043555 (DuPont Industrial Biosciences), 10166 CMC- DNS/g, 185 MVU/g.
  • LAMINEX® BG2 is a commercial preparation of an enzyme complex capable of hydrolyzing beta-glucans and related carbohydrates. It is produced by fermentation with a selected strain of Trichoderma reesei.
  • LAMINEX® BG2 comprises: water 59 - 71 % (w/w); cellulase 15 - 20 % (w/w); sorbitol 10.0 - 15.0 % (w/w); sodium chloride 4.0 - 5.0 % (w/w); and sodium benzoate 0.00 - 0.50 % (w/w).
  • LAMINEX® Super 3G (DuPont Industrial Biosciences). LAMINEX® Super 3G is a commercial preparation of enzyme complex capable of hydrolyzing beta-glucans, pentosans and related carbohydrates. LAMINEX® Super 3G is produced by fermentation with selected strains of Trichoderma reesei and Penicillum funiculosum. LAMINEX® Super 3G comprises: water 75.8 - 80.8 % (w/w); cellulase 15 - 20 % (w/w); sorbitol 6.50 % (w/w); sodium chloride 2.20 % (w/w); and sodium benzoate 0.50 % (w/w).
  • LAMINEX® C2K (DuPont Industrial Biosciences).
  • LAMINEX® C2K is a commercial preparation comprising a cellulase enzyme composition (EC 3.2.1.4) derived from Penicillum funiculosum containing other minor enzyme activities. These include beta-glucanase (EC 3.2.1.6), xylanase (EC 3.2.1.8), and glucan endo-1 ,3-B-D-glucosidase (EC3.2.1.39).
  • Palm Liquid and enzyme was incubated with magnetic stirring at 50 °C or 60 °C for 0.5 or 4 hours. After incubation the sample was placed in at waterbath at 95 degrees for 10 minutes to stop the enzyme reaction, and transferred to a tarred 50 mL centrifuge tube. The upper oil layer was removed, and a sample of the water phase was taken out for glucose analyses and remaining water phase was discharged. 30 mL water at 50 °C was added to each tube. The sample was centrifuged at 4180 rcf and 60 °C for 10 minutes.
  • the water phase was removed and the side of the tube was wiped with a tissue to remove residual oil on the inside of the tube.
  • the wet sediment was scaled, frozen and freeze dried. Weight of the dry sediment was determined after freeze drying.
  • the dry sediment was grounded for 25 sec at 25000rpm in IKA Tube-mill. 150 mg grounded sediment was scaled in a 15 centrifuge tube and added 7.5 ml_ heptane:isopropanol (IPA) 3:2. The mixture was heated to 40 °C for 10 minutes and mixed for 30 minutes at Stuart rotator SB2.
  • IPA isopropanol
  • the mixture was centrifuged for 3 min at 1280 rcf. 1 mL of the supernatant was transferred to TLC vials. The triglyceride in the sample was calculated based on a calibration curve for palm oil analyzed in the same way.
  • Standard solutions of 0.5% Palm Oil (0.2, 0.5, 0.8, 1.2, 1.8 and 2.5 respectively) were also applied to the HPTLC plate by an automatic TLC applicator.
  • the plate was eluted (7cm) with Running buffer: Heptane: Methyl-Tert-Butyl-ether (MTBE): Acetic acid 70:30:1. After elution the plate was dried on a plate heater for 2 minutes at 160 °C, cooled, and dipped in 6% cupric acetate in 16% H 3 P0 4 . The plate was additionally dried for 6 minutes at 160 °C.
  • the developed spots were quantified using a TLC plate scanner and components quantified based on calibration curves of the palm oil standard.
  • Glucose in the supernatant from the centrifuged sludge was analyzed by HPLC using a Dionex Ultimate 3000 HPLC system (Thermo Fisher Scientific) equipped with a DGP- 3600SD Dual-Gradient analytical pump, WPS-3000TSL thermostated autosampler, TCC- 3000SD thermostated column oven, and a RI-101 refractive index detector (Shodex, JM Science). Chromeleon datasystem software (Version 6.80, DU10A Build 2826, 171948) was used for data acquisition and analysis.
  • the column used was a RSO oligosaccharide column, Ag + 4% cross-linked (Phenomenex, The Netherlands) equipped with an analytical guard column (Carbo-Ag + neutral, AJO-4491 , Phenomenex, The Netherlands) at 70 °C.
  • the column was eluted with double distilled water (filtered through a regenerated cellulose membrane of 0.45 ⁇ and purged with helium gas) at a flow rate of 0.3 mL/min.
  • Glucose was quantified by construction of a calibration curve from analysis of D-(+)-glucose (min 99.5%, Sigma no G8270-100G).
  • reaction time and impact of agitation the enzymes were tested in the following recipes (Table 1). Table 1. Dosage, reaction time and impact of agitation the enzymes recipes,
  • the experiment also confirms that LAMINEX® BG2 works on the same level without agitation as with agitation, which is important for use of the enzyme in a clarifier where oil is separated from the sludge by gravity and without any agitation. Water content in the wet sediment is reduced by the enzyme treatment. This indicate that the water holing capacity is reduced because the carbohydrate polymer are degraded to smaller molecules, which has less water binding.
  • LAMINEX® BG2 Four different enzyme preparations LAMINEX® BG2, LAMINEX® Super 3G, LAMINEX® 750 and LAMINEX® C2K were tested in pressed palm liquid. After enzyme treatment the pressed palm liquid was separated into an oil phase, a water phase and sediment. Residual oil in sediment was analysed, which showed that LAMINEX® BG2 and LAMINEX® Super 3G contributed to a strong decrease in residual oil in sediment, and also the amount of sediment was reduced because of solubilisation of insoluble carbohydrates. This was confirmed by a significant increase in amount of glucose in the water phase. LAMINEX® 750 has very little effect on release of oil in sediment and only small amount of glucose was produced. LAMINEX® C2K had similar performance as LAMINEX® 750. EXAMPLE 3
  • Pressed palm liquid obtained by pressing the digested palm fruitlets is a rather viscous liquid. It is therefore normal procedure to dilute the pressed palm liquid with water before going to the clarifier in order to reduce viscosity.
  • Enzyme LAMINEX® BG2 batch no. 4902043555 (DuPont Industrial Biosciences), 10166
  • the viscosity was calculated as the average of measurements for 1 minute at each temperature.
  • the sample was then transferred to a 50-mL centrifuge tube and heated to 70 °C for 10 minutes, and then turned upside down 10 times.
  • the oil separation of the sample was followed visually for 10 minutes.
  • the oil separation for the sample was measured as the volume % of upper oil layer after 10 minutes.
  • the sample was then centrifuged at 4180 rcf for 10 minutes at 60 °C.
  • the upper oil layer and water was removed. 30 mL water at 50 °C was added to each tube without mixing.
  • the sample was centrifuged at 4180 rcf for 10 minutes at 60 °C.
  • the water phase was removed and the inside of the tube was wiped with a tissue to remove residual oil. Weight of the wet sediment was determined. The wet sediment was scaled, frozen and freeze dried.
  • Weight of the dry sediment was determined after freeze drying.
  • the dry sediment was grounded for 25 sec at 25000rpm in IKA Tube-mill.
  • Standard solutions of 0.5% Palm Oil (0.2, 0.5, 0.8, 1.2, 1.8 and 2.5 respectively) were also applied to the HPTLC plate by an automatic TLC applicator.
  • the plate was eluted (7cm) with Running buffer: Heptane: MTBE: Acetic acid 70:30:1. After elution the plate was dried on a plate heater for 2 minutes at 160 °C, cooled, and dipped in 6% cupric acetate in 16% H 3 P0 4 . The plate was additionally dried for 6 minutes at 160 °C.
  • the developed spots were quantified using a TLC plate scanner and components quantified based on calibration curves of the palm oil standard.
  • LAMINEX BG2 had a clear effect on solubilization of insoluble dry matter in pressed liquid, but also MANNASTAR® 375 and MULTIFECT® pectinase FE improved the solubilisation of insoluble dry matter.
  • Protease - PROTEX® 14L had a negative effect on oil release form insoluble dry matter.
  • LAMINEX® BG2 is able to solubilize 50% or more of the insoluble substrate in pressed palm liquid. Together with this solubilization it has been observed that amount of bound oil in the sediment is reduced by more than 60%. Studies have also shown that other cellulose degrading enzymes may not be as efficient as LAMINEX® BG2.
  • MANNASTAR® 375 is a mannanase preparation obtained by fermentation of Trichoderma reesei (DuPont Industrial Biosciences). In this study combination of LAMINEX® BG2 with MULTIFECT® Pectinase FE was also investigated.
  • LAMINEX® BG2 batch no. 4902043555 (DuPont Industrial Biosciences), 10166 CMC- DNS/g, 185 MVU/g Mannanase, MANNASTAR® 375 batch no. 4881561660.
  • MANNASTAR® 375 is a commercial preparation comprising mannanase activity (Danisco USA).
  • Pectinase MULTIFECT® pectinase FE batch no.4861512246.
  • MULTIFECT® Pectinase FE DuPont Industrial Biosciences is a commercial preparation of a pectinase complex derived from a strain of Aspergillus niger.
  • PROTEX® 14L is a commercial protease preparation comprising a protease from Geobacillus sp.. (DuPont Industrial Biosciences).
  • Palm Liquid and enzyme was incubated with magnetic stirring at 50 °C 4 hours. After incubation the sample was transferred to a tarred 50 mL centrifuge tube and placed in a water bath at 95 degrees for 10 minutes to stop the enzyme reaction.
  • the sample was centrifuged at 4180 rcf and 60 °C for 10 minutes.
  • the upper oil layer was removed, and a sample of the water phase was taken out for glucose analyses and remaining water phase was discharged. 30 mL water at 50 °C was added to each tube without mixing. The sample was centrifuged at 4180 rcf and 60 °C for 10 minutes.
  • the water phase was removed and the inside of the tube was wiped with a tissue to remove residual oil and water.
  • the wet sediment was scaled, frozen and freeze dried. Weight of the dry sediment was determined after freeze drying.
  • the dry sediment was grounded for 25 sec at 25000 rpm in IKA Tube-mill.
  • the mixture was centrifuged for 3 min at 1280 rcf. 1 mL of the supernatant was transferred to TLC vials, and triglycerides determined by TLC.
  • the triglyceride in the sample was calculated based on a calibration curve for palm oil analyzed in the same way.
  • Standard solutions of 0.5% Palm Oil (0.2, 0.5, 0.8, 1.2, 1.8 and 2.5 respectively) were also applied to the HPTLC plate by an automatic TLC applicator.
  • the plate was eluted (7cm) with Running buffer: Heptane: TBE: Acetic acid 70:30:1. After elution the plate was dried on a plate heater for 2 minutes at 160 °C, cooled, and dipped in 6% cupric acetate in 16% H 3 P0 4 . The plate was additionally dried for 6 minutes at 160 °C.
  • the developed spots were quantified using a TLC plate scanner and components quantified based on calibration curves of the palm oil standard.
  • Table 1 Recipes of LAMINEX® BG2 tested in pressed palm liquid.
  • protease PROTEX® 14L has a negative effect on release of oil from sediment, this might be explained by solubilization of protein and formation of peptides with emulsification properties.
  • Pressed palm liquid obtained by pressing the digested palm fruitlets is a rather viscous liquid. It is therefore normal procedure to dilute the pressed palm liquid with water before going to the clarifier in order to reduce viscosity.
  • LAMINEX® BG2 batch no. 4902043555 (DuPont Industrial Biosciences), 10166 CMC- DNS/g, 185 MVU/g
  • the viscosity of the sample was immediately measure using a Rapid Visco Analyzer using the following program, Agitation 400 rpm, temperature setting 60 °C for 2 minutes Increase temperature to 80 °C, keep 80 °C for 3 minutes
  • the viscosity at 60 °C was calculated as the average of measurements between 60 and 120 seconds and viscosity at 80 °C was calculated as average measurements between 300 and 360 seconds.
  • the sample was then transferred to a 50-mL centrifuge tube and centrifuged at 4180 rcf for 10 minutes at 60 °C.The upper oil layer and water was removed.
  • the water phase was removed and the inside of the tube was wiped with a tissue to remove residual oil. Weight of the wet sediment was determined. The wet sediment was scaled, frozen and freeze dried.
  • Weight of the dry sediment was determined after freeze drying.
  • the dry sediment was grounded for 25 sec at 25000rpm in IKA Tube-mill.
  • the mixture was centrifuged for 3 min at 1280 rcf. 1 mL of the supernatant was transferred to TLC vials.
  • the triglyceride in the sample was calculated based on a calibration curve for palm oil analyzed in the same way.
  • the sample (1 ,0 ⁇ ) was applied to the 10 x 20 cm Silica HPTLC plate.
  • Standard solutions of 0.5% Palm Oil (0.2, 0.5, 0.8, 1.2, 1.8 and 2.5 respectively) were also applied to the HPTLC plate by an automatic TLC applicator.
  • the plate was eluted (7 cm) with Running buffer: Heptane: MTBE: Acetic acid 70:30:1. After elution the plate was dried on a plate heater for 2 minutes at 160 °C, cooled, and dipped in 6% cupric acetate in 16% H 3 P0 4 . The plate was additionally dried for 6 minutes at 160 °C.
  • the developed spots were quantified using a TLC plate scanner and components quantified based on calibration curves of the palm oil standard.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
EP15820488.3A 2014-12-19 2015-12-18 Verfahren zur verbesserung der palmölausbeute aus der palmenfrucht oder aus palmenfruchtflüssigkeit Withdrawn EP3234081A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
MYPI2014703901 2014-12-19
MYPI2014703902 2014-12-19
PCT/EP2015/080441 WO2016097266A1 (en) 2014-12-19 2015-12-18 Method of improving palm oil yields from palm fruit or palm fruit liquid

Publications (1)

Publication Number Publication Date
EP3234081A1 true EP3234081A1 (de) 2017-10-25

Family

ID=55071001

Family Applications (2)

Application Number Title Priority Date Filing Date
EP15820487.5A Not-in-force EP3234083B1 (de) 2014-12-19 2015-12-18 Rückgewinnung von öl aus palmschlamm
EP15820488.3A Withdrawn EP3234081A1 (de) 2014-12-19 2015-12-18 Verfahren zur verbesserung der palmölausbeute aus der palmenfrucht oder aus palmenfruchtflüssigkeit

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP15820487.5A Not-in-force EP3234083B1 (de) 2014-12-19 2015-12-18 Rückgewinnung von öl aus palmschlamm

Country Status (6)

Country Link
EP (2) EP3234083B1 (de)
BR (2) BR112017013025A2 (de)
CO (2) CO2017006978A2 (de)
DK (1) DK3234083T3 (de)
EC (2) ECSP17045070A (de)
WO (2) WO2016097264A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY197084A (en) 2016-04-22 2023-05-24 Novozymes As Enzyme-assisted oil extraction using sterilizer condensate
WO2019068850A1 (en) 2017-10-06 2019-04-11 Novozymes A/S EXTRACTION OF ENZYME-ASSISTED GROSS PALM OIL
RU2714115C2 (ru) 2018-06-21 2020-02-11 Общество с ограниченной ответственностью "НПО БиоМикроГели" Применение микрогеля полисахарида при производстве растительного масла, реагенты на основе микрогеля полисахарида и способ производства растительного масла с их использованием
CN111518611A (zh) * 2020-04-28 2020-08-11 上海容邦企业集团有限公司 沙棘果油复合物及制备方法
CN111793523B (zh) * 2020-07-07 2023-06-02 蚌埠市江淮粮油有限公司 一种米糠油的脱胶方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU83441A1 (fr) * 1981-06-19 1983-04-06 Tirtiaux Sa Procede de traitement des huiles et graisses et produits ainsi obtenus
US5554520A (en) 1988-08-31 1996-09-10 Bioenergy International, L.C. Ethanol production by recombinant hosts
US5482846A (en) 1988-08-31 1996-01-09 University Of Florida Ethanol production in Gram-positive microbes
US5000000A (en) 1988-08-31 1991-03-19 University Of Florida Ethanol production by Escherichia coli strains co-expressing Zymomonas PDC and ADH genes
US5487989A (en) 1988-08-31 1996-01-30 Bioenergy International, L.C. Ethanol production by recombinant hosts
US5028539A (en) 1988-08-31 1991-07-02 The University Of Florida Ethanol production using engineered mutant E. coli
US5424202A (en) 1988-08-31 1995-06-13 The University Of Florida Ethanol production by recombinant hosts
DE69107455T3 (de) 1990-05-09 2004-09-23 Novozymes A/S Eine ein endoglucanase enzym enthaltende zellulasezubereitung.
NL9001388A (nl) 1990-06-19 1992-01-16 Unilever Nv Recombinant dna, cel die daarvan afgeleid dna bevat, enzym waarvoor het recombinant dna codeert en toepassingen daarvan.
IE20040144A1 (en) 1990-07-24 2004-05-19 Dsm Nv Cloning and expression of xylanase genes from fungal origin
DK194990D0 (da) 1990-08-16 1990-08-16 Novo Nordisk As Aldc-derivat og anvendelse deraf
EP0579672B1 (de) 1991-04-02 1999-02-03 Novo Nordisk A/S Xylanase, entsprechende rekombinante dna-sequenz, xylanase enthaltendes agens, und seine verwendung
DK0695349T3 (da) 1993-03-10 2004-06-01 Novozymes As Enzymer med xylanaseaktivitet stammende fra Aspergillus Aculeatus
US5514583A (en) 1994-04-15 1996-05-07 Midwest Research Institute Recombinant zymomonas for pentose fermentation
DE19527274A1 (de) 1995-07-26 1997-01-30 Metallgesellschaft Ag Enzymatisches Verfahren zur Entschleimung von pflanzlichen Ölen mit Aspergillus-Phospholipase
US5811381A (en) 1996-10-10 1998-09-22 Mark A. Emalfarb Cellulase compositions and methods of use
CN101818177A (zh) 2004-07-16 2010-09-01 丹尼斯科公司 脂肪分解酶及其在食品工业中的应用
US7846705B2 (en) 2006-07-18 2010-12-07 Direvo Industrial Biotechnology Gmbh Mannanases
AU2008339660B2 (en) 2007-12-21 2013-09-26 Dupont Nutrition Biosciences Aps Process for edible oil refining using a lipid acyltransferase
US9163050B2 (en) * 2012-08-06 2015-10-20 Orochem Technologies, Inc. Mannose production from palm kernel meal using simulated moving bed separation
KR101408840B1 (ko) * 2012-11-09 2014-06-19 한국화학연구원 팜유 제조 공정 부산물을 이용한 농후사료 및 이의 제조방법
EP3126509A1 (de) * 2014-04-01 2017-02-08 DuPont Nutrition Biosciences ApS Verfahren zur erhöhung der rohpalmölerträge
AU2015101377B4 (en) * 2014-12-19 2017-02-02 Dupont Nutrition Biosciences Aps Method of treating a palm fruit or a palm fruit liquid

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BOUVIER F. ET AL: "Use of Cellulase and Pectinase in the Palm Oil Extraction Process",", REVUE FRANÇAIS DES CORPS GRAS, vol. 39, no. 9/10, 1 October 1992 (1992-10-01), pages 245 - 252, XP055538795 *
See also references of WO2016097266A1 *

Also Published As

Publication number Publication date
CO2017006977A2 (es) 2017-10-10
EP3234083A1 (de) 2017-10-25
EP3234083B1 (de) 2018-12-12
BR112017013025A2 (pt) 2018-01-02
WO2016097266A1 (en) 2016-06-23
DK3234083T3 (en) 2019-04-01
BR112017013040A2 (pt) 2018-01-09
ECSP17045070A (es) 2017-10-31
WO2016097264A1 (en) 2016-06-23
ECSP17045069A (es) 2017-09-29
CO2017006978A2 (es) 2017-10-20

Similar Documents

Publication Publication Date Title
AU2015101377A4 (en) Method of treating a palm fruit or a palm fruit liquid
Ahmed et al. Microbial β-glucosidase: sources, production and applications
Shah et al. Xylanase production by a newly isolated Aspergillus foetidus strain and its characterization
ES2455269T3 (es) Variantes de beta-glucosidasa recombinante para la producción de azúcares solubles de biomasa celulósica
Kallel et al. Production of xylooligosaccharides from garlic straw xylan by purified xylanase from Bacillus mojavensis UEB-FK and their in vitro evaluation as prebiotics
RU2433140C2 (ru) Слитые белки, включающие ферменты, разрушающие клеточную оболочку растений, и их применения
EP3234083B1 (de) Rückgewinnung von öl aus palmschlamm
Faulds et al. Synergy between xylanases from glycoside hydrolase family 10 and family 11 and a feruloyl esterase in the release of phenolic acids from cereal arabinoxylan
EA031037B1 (ru) Способ получения сахарного продукта из лигноцеллюлозного материала
CN102834521A (zh) 用于增强来自发酵工艺副产物的方法
EA016528B1 (ru) Создание химических строительных блоков из растительной биомассы посредством избирательной деполимеризации
US20170121741A1 (en) Method for increasing crude palm oil yields
Sun et al. The optimization of fermentation conditions for Pichia pastoris GS115 producing recombinant xylanase
Dhiman et al. Recent advances and industrial applications of microbial xylanases: a review
US7635471B2 (en) Xylanase gene sequences from the genomic DNA of unpurified rumen microorganisms
US8916366B2 (en) Multi-cellulase enzyme compositions for hydrolysis of cellulosic biomass
JP6890134B2 (ja) 前処理されたリグノセルロース系搾汁残渣によってセルラーゼを生産するための方法
CN112074602A (zh) 具有改善的热稳定性和对阿拉伯木聚糖增加的酶活性的新木聚糖酶
EP3541948B1 (de) Verfahren zur verbesserung des nährwerts von fermentationsnebenprodukten
US9416377B2 (en) Cellulolytic enzyme enhancement of dry grind corn processing and ethanol production
Lepcha et al. Glycoside hydrolases from a thermophilic microbial consortium and their implication in the saccharification of agroresidues
Cheawchanlertfa et al. A novel amylolytic/xylanolytic/cellulolytic multienzyme complex from Clostridium manihotivorum that hydrolyzes polysaccharides in cassava pulp
Meryandini et al. Characterization of xylanase Streptomyces spp. SKK1-8
US20100256353A1 (en) Use of type c and d feruloyl esterases in the manufacture of biofuels
Hernández et al. Xylan-binding xylanase Xyl30 from Streptomyces avermitilis: cloning, characterization, and overproduction in solid-state fermentation

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20170718

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RIN1 Information on inventor provided before grant (corrected)

Inventor name: KJAER, KARINA HANSEN

Inventor name: LEE, LAI SEE

Inventor name: SOEE, JOERN BORCH

Inventor name: MIKKELSEN, RENE

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20180619

TPAC Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOSNTIPA

RIC1 Information provided on ipc code assigned before grant

Ipc: C11B 1/02 20060101ALI20191127BHEP

Ipc: C11B 1/06 20060101AFI20191127BHEP

Ipc: C11B 13/00 20060101ALI20191127BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20200107

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20200603